Using transgenic mice to analyze the mechanisms of progression of chronic renal failure

Journal of the American Society of Nephrology

Volumn 11, Issue SUPPL. 16, 2000, Pages

  Terzi, F ^a   Burtin, M ^a   Friedlander, G ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY FAILURE; KIDNEY INJURY; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

EID: 0033764065     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Experimental models of nephron reduction: Some answers, many questions
2. Subtotal but not unilateral nephrectomy induces hyperplasia and protooncogene expression
3. Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice
4. The course of the remnant kidney model in mice
5. The lack of a functional p21(WAF1/CIP1) gene ameliorates progression to chronic renal failure
6. Progression of renal disease and renal hypertrophy
7. Targeted oncogenesis: A powerful method to derive renal cell lines
8. Gene transfer into the kidney: Promise for unravelling disease mechanisms, limitations for human gene therapy
9. Transgenic animal models of renal development and pathogenesis
10. Early molecular mechanisms in the progression of renal failure: Role of growth factors and protooncogenes
11. Physiological consequences of over- or under-expression of fibrinolytic system components in transgenic mice
12. Gene targeting in nephrology
13. Intermediate filaments: Structure, dynamics, function, and disease
14. Shear stress induces changes in the morphology and cytoskeleton organisation of arterial endothelial cells
15. Mice lacking vimentin develop and reproduce without an obvious phenotype
16. Normal tubular regeneration and differentiation of the post-ischemic kidney in mice lacking vimentin
17. Reduction of renal mass is lethal in mice lacking vimentin: Role of endothelin-nitric oxide balance
18. Flow-mediated endothelial mechanotransduction
19. Increased distal nephron EGF content and altered distribution of peptide in compensatory renal hypertrophy
20. Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease
21. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: Correlation with metastatic behavior and prognosis
22. Renal cysts in transgenic mice expressing transforming growth factor-alpha
23. An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice
24. Targeting of the rasT 24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys
25. Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease
26. Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice
27. Renal effect of anti-hypertensive drugs depends on sodium diet in the excision remnant kidney model
28. Sodium restriction decreases AP-l activation after nephron reduction in the rat: Role in the progression of renal lesions
29. Targeted expression of a dominant negative epidermal growth factor receptor in the kidney reduces tubulo-interstitial lesions after renal injury
30. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase
31. Cellular pathophysiology of cystic kidney disease: Insight into future therapies
32. Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice
33. Reversal of lung lesions in transgenic transforming growth factor alpha mice by expression of mutant epidermal growth factor receptor
34. Early role of Fspl in epithelial-mesenchymal transformation
35. 1-independent mechanism
36. Progression of renal damage in human glomerulonephritides: Is there sleight of hand in winning the game?
37. What role does apoptosis play in progression of renal disease?
38. Bcl-2 genes and growth factors in the pathology of ischaemic acute renal failure
39. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice
40. Targeted disruption of the murine junD gene results in multiple defects in male reproductive function
41. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry
42. AP-function and regulation
43. Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by Ras
44. Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor